Skip to main content

AMERIPRISE FINANCIAL INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 820027 MINNEAPOLIS, MN

Position in ACAD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$13,896,025
-$3,792,431 QoQ
Shares Held
624,260
-5.7% QoQ
Ownership
0.365%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 94.86207669881139.ToString("F0")% None 5.137923301188607.ToString("F0")%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. ACAD ranks #36 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACAD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,896,025 624,260
2025-12-31 $17,688,456 662,241
2025-09-30 $14,615,380 684,882
2025-06-30 $13,728,289 636,453
2025-03-31 $11,574,261 696,825
2024-12-31 $16,237,361 884,870
2024-09-30 $11,748,379 763,874
2024-06-30 $12,067,994 742,646
2024-03-31 $13,722,962 742,183
2023-12-31 $20,261,073 647,112
2023-09-30 $12,076,922 579,507
2023-06-30 $13,604,699 568,046
2023-03-31 $10,924,537 580,475
2022-12-31 $8,330,871 523,296
2022-09-30 $15,211,641 929,807
2022-06-30 $13,315,894 945,060
2022-03-31 $26,146,481 1,079,541
2021-12-31 $27,034,673 1,158,298
2021-09-30 $18,749,034 1,128,780
2021-06-30 $31,676,218 1,298,738
2021-03-31 $62,798,514 2,434,051
2020-12-31 $67,654,162 1,265,510
2020-09-30 $50,160,288 1,216,007
2020-06-30 $105,033,227 2,166,974
2020-03-31 $67,262,675 1,592,016